Major cardiac events were fewer at 5 years in patients receiving a radial artery graft as the second conduit in coronary bypass surgery (CABG) vs a saphenous-vein graft (SVG) in a patient-level ...
MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...
Relying entirely on arteries as a source for grafts in CABG appears to impart better survival for patients irrespective of age, according to a new analysis of registry data from Australia and New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results